Delivery Order SPE2DB24D2013-SPE2DB25FCHCC

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHCC
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,653.90 firm fixed-price contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support military healthcare programs.

The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. This IDC, running through November 2026, encompasses a broad spectrum of critical medical commodities including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract award does not have a set-aside designation, indicating open competition.

Generated 3/27/25, 9:57 AM